
Randeep Singh
Examiner (ID: 377)
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 524 |
| Issued Applications | 328 |
| Pending Applications | 7 |
| Abandoned Applications | 192 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11053196
[patent_doc_number] => 20160250159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITION, USE THEREOF, AND METHODS OF MANUFACTURING'
[patent_app_type] => utility
[patent_app_number] => 15/048613
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10591
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048613
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048613 | COMPOSITION, USE THEREOF, AND METHODS OF MANUFACTURING | Feb 18, 2016 | Abandoned |
Array
(
[id] => 10805133
[patent_doc_number] => 20160151290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/019315
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20327
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019315 | Pharmaceutical Formulation Containing Gelling Agent | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10805140
[patent_doc_number] => 20160151297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/019304
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20325
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019304 | Pharmaceutical formulation containing gelling agent | Feb 8, 2016 | Issued |
Array
(
[id] => 12111806
[patent_doc_number] => 09867784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 15/019195
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20513
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019195
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019195 | Pharmaceutical formulation containing gelling agent | Feb 8, 2016 | Issued |
Array
(
[id] => 10805203
[patent_doc_number] => 20160151360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/019222
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20327
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019222
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019222 | Pharmaceutical Formulation Containing Gelling Agent | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10805134
[patent_doc_number] => 20160151291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/019321
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20324
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019321 | Pharmaceutical Formulation Containing Gelling Agent | Feb 8, 2016 | Abandoned |
Array
(
[id] => 10805132
[patent_doc_number] => 20160151289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/019281
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20325
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019281 | Pharmaceutical formulation containing gelling agent | Feb 8, 2016 | Issued |
Array
(
[id] => 14323897
[patent_doc_number] => 10292941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Adhesive patch
[patent_app_type] => utility
[patent_app_number] => 15/547645
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5476
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547645 | Adhesive patch | Feb 4, 2016 | Issued |
Array
(
[id] => 11721116
[patent_doc_number] => 09693961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 15/015722
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20512
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015722 | Pharmaceutical formulation containing gelling agent | Feb 3, 2016 | Issued |
Array
(
[id] => 10805345
[patent_doc_number] => 20160151502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/015708
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20327
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015708 | Pharmaceutical Formulation Containing Gelling Agent | Feb 3, 2016 | Abandoned |
Array
(
[id] => 12960100
[patent_doc_number] => 09872836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Pharmaceutical formulation containing gelling agent
[patent_app_type] => utility
[patent_app_number] => 15/015735
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19328
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015735 | Pharmaceutical formulation containing gelling agent | Feb 3, 2016 | Issued |
Array
(
[id] => 10805201
[patent_doc_number] => 20160151358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/015769
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20327
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015769 | Pharmaceutical formulation containing gelling agent | Feb 3, 2016 | Issued |
Array
(
[id] => 10805200
[patent_doc_number] => 20160151357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/015763
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20325
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015763 | Pharmaceutical formulation containing gelling agent | Feb 3, 2016 | Issued |
Array
(
[id] => 10805342
[patent_doc_number] => 20160151499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Pharmaceutical Formulation Containing Gelling Agent'
[patent_app_type] => utility
[patent_app_number] => 15/013628
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20326
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013628
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/013628 | Pharmaceutical formulation containing gelling agent | Feb 1, 2016 | Issued |
Array
(
[id] => 11342310
[patent_doc_number] => 09526696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis'
[patent_app_type] => utility
[patent_app_number] => 15/012849
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11208
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012849
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012849 | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | Jan 31, 2016 | Issued |
Array
(
[id] => 11342311
[patent_doc_number] => 09526698
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis'
[patent_app_type] => utility
[patent_app_number] => 15/012851
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11205
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012851 | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | Jan 31, 2016 | Issued |
Array
(
[id] => 11342312
[patent_doc_number] => 09526697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis'
[patent_app_type] => utility
[patent_app_number] => 15/012850
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11209
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012850 | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | Jan 31, 2016 | Issued |
Array
(
[id] => 10797690
[patent_doc_number] => 20160143847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'FORMULATIONS OF AMINOGLYCOSIDE AND FOSFOMYCIN COMBINATIONS AND METHODS AND SYSTEMS FOR TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) AND VENTILATOR ASSOCIATED TRACHEAL (VAT) BRONCHITIS'
[patent_app_type] => utility
[patent_app_number] => 15/012847
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11198
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012847 | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | Jan 31, 2016 | Issued |
Array
(
[id] => 10790136
[patent_doc_number] => 20160136292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 15/005184
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 42890
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005184
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005184 | METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION | Jan 24, 2016 | Abandoned |
Array
(
[id] => 13116355
[patent_doc_number] => 10076513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
[patent_app_type] => utility
[patent_app_number] => 15/001036
[patent_app_country] => US
[patent_app_date] => 2016-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 27114
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001036
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/001036 | Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof | Jan 18, 2016 | Issued |